Anita Brikman: There Are Countless More Individuals Who Would Benefit from Access to Plasma-Derived Medicines
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”As International Plasma Awareness Week comes to a close, I’m grateful to all who supported the incredible efforts to recognize the lifesaving power of plasma and plasma donors. It was truly moving to see how Plasma Powers Possibility for so many around the globe.
But it is also clear that our mission doesn’t stop here. There are countless more individuals who would benefit from access to plasma-derived medicines, especially those in lower and middle income countries where the availability of treatment for rare diseases is limited at best.
The Plasma Protein Therapeutics Association (PPTA) efforts around awareness, advocacy, and access will continue on a daily basis. Because in reality, every week should be an awareness week filled with opportunities to reach out and educate. Pictured below are some of our awareness and activities from IPAW2025 including a powerful patient webinar, a Brussels panel on the Critical Medicines Act, a moving patient and donor meeting with GBS|CIDP Foundation International, and just one of the many patient testimonials we received over the last few days.
Next week, the momentum continues at the Plasma Protein Forum, where industry leaders, health care providers, and patient advocates will come together to advance innovation and address timely issues that impact the entire plasma community.
There’s still time to register, and I hope to see many of you there.
Visit the forum for more details on next week’s gathering.”

Stay updated with Hemostasis Today.
-
Feb 23, 2026, 16:36Stéphanie Roullet։ New Method to Explore Primary Haemostasis in Cirrhotic Patients
-
Feb 23, 2026, 16:33Salvatore Massimo Petrina: Top 5 Game-Changers in the AHA and ACC PE Guidelines
-
Feb 23, 2026, 16:21Azin Alizadehasl: Introducing the Second Edition of a New Book on Echocardiography and Cardiac MRI
-
Feb 23, 2026, 16:16Kalyan Roy: When and Why Blood Irradiation Matters in Transfusion Medicine
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology